Rational use of analgesic and antiinflammatory drugs

New England Journal of Medicine

Volumn 345, Issue 25, 2001, Pages 1844-1846

  Crofford, Leslie J ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANTIINFLAMMATORY AGENT; CYCLOOXYGENASE 2 INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; ROFECOXIB;

DIGESTIVE SYSTEM ULCER; DRUG EFFICACY; DRUG TOLERABILITY; DRUG USE; EDITORIAL; GASTROINTESTINAL HEMORRHAGE; HUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; THROMBOCYTE FUNCTION; TREATMENT INDICATION;

ACETAMINOPHEN; ANALGESICS, NON-NARCOTIC; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; HUMANS; ISOENZYMES; KIDNEY FAILURE, CHRONIC; MEMBRANE PROTEINS; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;

EID: 0035924780     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200112203452512     Document Type: Editorial

References (18)

1. Basic biology and clinical application of specific cyclooxygenase-2 inhibitors
2. Platelet-active drugs: The relationships among dose, effectiveness, and side effects
3. Prevention of death, myocardial infarction and stroke by antiplatelet therapy in high risk patients
4. The coxibs, selective inhibitors of cyclooxy-genase-2
5. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 Update
6. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis
7. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: The CLASS study: A randomized controlled trial
8. Relative risk of upper gastrointestinal complications among users of acetamìnopnen and nonsteroidal anti-inflammatory drugs
9. Cyclooxygenase inhibition and thrombogenicity
10. Renal effects of COX-2-selective inhibitors
11. Cyclooxygenase inhibitors and the antiplatelet effects of aspirin
12. Acetaminophen, aspirin, and chronic renal failure
13. Mechanism of acetaminophen inhibition of cyclooxygenase isoforms
14. Effects of selective cyclooxygenase-2 inhibition on vascular responses and thrombosis in canine coronary arteries
15. Differential effects of aspirin and non-aspirin nonsteroidal antiinflammatory drugs in the primary prevention of myocardial infarction in postmenopausal women
16. Risk of cardiovascular events associated with selective COX-2 inhibitors
17. Cardiovascular thrombotic events in controlled, clinical trials of rofecoxib
18. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs